BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17507042)

  • 1. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
    Hedlund P; Streng T; Lee T; Andersson KE
    J Urol; 2007 Jul; 178(1):326-31. PubMed ID: 17507042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats.
    Yokoyama O; Yusup A; Miwa Y; Oyama N; Aoki Y; Akino H
    J Urol; 2005 Nov; 174(5):2032-6. PubMed ID: 16217388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
    Streng T; Andersson KE; Hedlund P; Gratzke C; Baroni E; D'Ambrosio D; Benigni F
    BJU Int; 2012 Jul; 110(2 Pt 2):E125-31. PubMed ID: 22288904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
    BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
    Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
    BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
    Angelico P; Velasco C; Guarneri L; Sironi G; Leonardi A; Testa R
    BMC Pharmacol; 2005 Oct; 5():14. PubMed ID: 16216132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
    Yusup A; Akino H; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Matsuta Y; Nakai M; Yokoyama O
    Eur J Pharmacol; 2007 Dec; 577(1-3):143-9. PubMed ID: 17904547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
    Suzuki M; Ohtake A; Yoshino T; Yuyama H; Hayashi A; Ukai M; Okutsu H; Noguchi Y; Sato S; Sasamata M
    Eur J Pharmacol; 2005 Apr; 512(1):61-6. PubMed ID: 15814091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents.
    Nagabukuro H; Villa KL; Wickham LA; Kulick AA; Gichuru L; Donnelly MJ; Voronin GO; Pereira T; Tong X; Nichols A; Alves SE; O'Neill GP; Johnson CV; Hickey EJ
    J Pharmacol Exp Ther; 2011 Jul; 338(1):220-7. PubMed ID: 21459965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolterodine activates the prefrontal cortex during bladder filling in OAB patients: a real-time NIRS-urodynamics study.
    Sakakibara ; Tateno F; Yano M; Takahashi O; Sugiyama M; Ogata T; Kishi M; Tsuyusaki Y; Yamamoto T; Uchiyama T; Yamanishi T; Shibata C
    Neurourol Urodyn; 2014 Sep; 33(7):1110-5. PubMed ID: 24038213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.
    Aizawa N; Ito H; Sugiyama R; Fujimura T; Suzuki M; Fukuhara H; Homma Y; Igawa Y
    J Urol; 2015 Apr; 193(4):1423-32. PubMed ID: 25219701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
    Fey TA; Gopalakrishnan M; Strake JG; King LL; Brioni JD; Sullivan JP; Coghlan MJ; Brune ME
    Neurourol Urodyn; 2003; 22(2):147-55. PubMed ID: 12579633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous contractile activity in the isolated rat bladder is modulated by a TRPV1 dependent mechanism.
    Gevaert T; Vandepitte J; Ost D; Nilius B; De Ridder D
    Neurourol Urodyn; 2007; 26(3):424-32; discussion 451-3. PubMed ID: 17004230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.
    Boy S; Schurch B; Mehnert U; Mehring G; Karsenty G; Reitz A
    BJU Int; 2007 Sep; 100(3):574-8. PubMed ID: 17669142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravesical capsaicin and resiniferatoxin on distension-induced bladder contraction in conscious rats with and without chronic spinal cord injury.
    Komiyama I; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
    J Urol; 1999 Jan; 161(1):314-9. PubMed ID: 10037430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.
    Yokoyama O; Yusup A; Oyama N; Aoki Y; Miwa Y; Akino H
    J Urol; 2007 Feb; 177(2):771-5. PubMed ID: 17222679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JTS-653 blocks afferent nerve firing and attenuates bladder overactivity without affecting normal voiding function.
    Kitagawa Y; Wada M; Kanehisa T; Miyai A; Usui K; Maekawa M; Sakata M; Matsuo A; Hayashi M; Matsushita M
    J Urol; 2013 Mar; 189(3):1137-46. PubMed ID: 22999996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.